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A
s a child in Finland, Jussi Taipale 
liked to tinker with electronics. 
But a missed application deadline 
prevented him from going to technical uni-
versity to study physics, which turned out 
to be a lucky thing for the fi  eld of biology.
Taipale went on to study biochemistry 
and soon conceived a love for growth factor 
signaling pathways. After fi  nishing  his 
graduate studies on TGF-β signaling (1), he 
obtained a postdoctoral 
position in Philip 
Beachy’s laboratory at 
Johns Hopkins Univer-
sity in Baltimore, where 
he joined the young fi  eld 
that was then coalescing 
around the signaling 
pathway regulated by 
the soluble protein 
Hedgehog. Hedgehog 
binds and inhibits the re-
ceptor Patched, thereby 
allowing the protein 
Smoothened to signal. Jussi has made sig-
nifi  cant contributions to the understanding 
of this pathway (2, 3).
Taipale then returned to Finland, 
where he’s now using genome-wide 
screens to generate reams of new insights 
about the inner workings of the cell (4, 5). 
He dug himself out from under a pile of 
data to talk with us about his work, which 
he delightedly describes as “the greatest 
job on Earth.”
MISSED DEADLINE
As a child, what did you want to be 
when you grew up?
I don’t remember exactly what I wanted to 
be. When I was 10 or 15 years old, I got 
interested in engineering, computers, elec-
tronics, and things like that. Later, when I 
graduated from high school, I wanted to 
study either physics or biochemistry. When 
it was time to apply to universities, there 
were two deadlines that I should have kept 
track of. The deadline at the technical uni-
versity, where I could have studied phys-
ics, was a day earlier than the one at the 
University of Helsinki, which offered a de-
gree in biochemistry. I, of course, got them 
confused and inadvertently applied a day 
late for physics. The technical university 
wouldn’t consider my late application and 
that’s how I ended up studying biology.
As a graduate student you studied 
growth factor signaling. What 
interested you about that topic?
All multicellular animals need to coordi-
nate cellular growth, and I thought that by 
understanding how this works normally, 
we could also gain insights about the cas-
es where things go wrong, for example, 
when breakdowns in signaling cascades 
lead to cancer.
But Finland is a small country, and 
there were very few laboratories where I 
could study growth factor signaling. My 
professors at the biochemistry department 
said that Jorma Keski-Oja’s laboratory 
was hiring people to study TGF-β signal-
ing, and so I joined that laboratory. TGF-β 
is known to regulate extracellular matrix 
synthesis. Our main focus was to under-
stand how TGF-β associates with and is 
released from the matrix.
FROM THE OUTSIDE IN
How did you come to study intracellular 
Hedgehog signaling as a post-doc?
After I fi  nished my graduate work, I stayed 
in Finland for a while to wait for my wife 
to fi  nish her PhD. While waiting, I looked 
at different growth factors for ideas that I 
could work on as a post-doc, and I worked 
for a year or so on vascular endothelial 
growth factor (VEGF) family signaling 
with Kari Alitalo. But I felt that both TGF-β 
and VEGF signaling were already pretty 
well understood, and wanted to work on 
something that held greater mysteries. I de-
cided to work on Hedgehog signaling, so I 
applied to Phil Beachy’s laboratory at 
Johns Hopkins and got a position there.
At that time the whole fi  eld was only 
about six years old, so everything was 
pretty new. I still had this idea that I should 
study stuff that happens outside of the cell. 
But with Hedgehog, it was obvious that 
there were lots of unknowns about what 
was happening inside of the cell, so that is 
what I ended up working on.
Your work with Dr. Beachy really 
helped move the Hedgehog ﬁ  eld 
forward. Did these advances come 
naturally to you?
I guess it helps that I had studied signal 
transduction for a while, so it was a fi  eld I 
could relate to. Also, if you spend several 
years thinking about a few molecules, you 
learn to think about things from different 
directions. Other people had already pub-
lished work on how they thought Hedge-
hog signaling would work, but we weren’t 
quite sure it worked that way. So we started 
from scratch.
We fi  rst studied cyclopamine, a plant-
derived chemical compound that was 
shown earlier by Michael Cooper to 
block Hedgehog signals. We found that 
cyclopamine blocked the pathway at the 
level of a protein called Smoothened. 
But if this protein’s activity was in-
creased by mutagenesis, it became more 
resistant to cyclopamine, resembling 
what pharmacologists would call an inverse 
Taipale is using genome-wide screens to gather information about the 
signaling pathways that control cell growth and cancer.
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agonist mechanism. Cyclopamine drives 
the population of activated Smoothened 
molecules to the inactive state by mass 
action—it specifi  cally binds to the inactive 
protein and locks it in that state. This 
helped explain how exogenous small 
molecules like cyclopamine can regulate 
Smoothened activity. Furthermore, the 
results suggested that Smoothened activ-
ity could also be regulated by endog-
enous small molecules, and that Patched 
might serve as a pump for these mole-
cules. It took a while for us to arrive at 
this model.
Why did you decide to return to 
Helsinki to start your own laboratory?
Well, I really liked America. My time in 
Baltimore was very nice, and I would’ve 
happily stayed there. But we had two chil-
dren at the time, and my wife wanted to 
return to Europe for family reasons.
It would have probably been better 
for my career if I had stayed in America. 
The research community there is much 
larger and it’s easier to fi  nd people to 
staff your lab. Here in Helsinki, we have 
a good department and many strong in-
vestigators, but we don’t have the same 
concentration of people as in the States. 
I get my pick of the top graduate stu-
dents in Finland, and they are great. But 
it can be diffi  cult to get others to come 
here. We have a reputation of being a 
very cold country, and very far from ev-
erything, most of which is not really 
true. It is cold, but it’s not Alaska. It’s 
more like Toronto or Boston, and the re-
search infrastructure and funding here 
are very good.
Personally, I like the way things work 
here. Finland is a Scandinavian country 
with a rather German tradition of how 
things work. Agreements tend to be held, 
which makes life simple. And of course, 
it’s a great country in which one can raise 
a family.
ON THE BRIGHT SIDE
You are using genome-wide screens to 
study Hedgehog signaling and cancer in 
your laboratory. What are the advantages 
and pitfalls of this approach?
When I started my own laboratory, I de-
cided that we would try to focus on growth 
control and on understanding how signal-
ing pathways drive growth. We have now 
worked our way to the nucleus, where we 
try to look at how the expression of genes 
linked to cell growth is regulated. We start 
out with a very global approach to iden-
tify cell cycle genes and the target genes 
of signaling pathways. By combining 
this information, we hope to come up 
with pathways we can then study in more 
detail. RNAi screening is a very powerful 
method for these kinds of global, large-
scale approaches.
I’ve always liked 
data—I like to have 
more data, as opposed 
to less. With these 
genome-wide  
approaches, you can 
come up with a large 
amount of data in a 
rather short timeframe, 
but that’s where the 
problems arise. You can 
get buried in the data, 
trying to interpret every little snippet, most 
of which is just noise in the initial screening. 
You have to spend a lot of time in analyzing 
each hit and each gene, and in trying to 
fi  gure out which ones are real, interesting, 
and represent novel fi  ndings. In this respect, 
it helps a lot to be computer literate. This 
work is not something for which many 
scientists are specifi  cally trained, and I am 
lucky that my early interests in engineering 
prepared me for it.
Do you have any words of wisdom for 
young scientists just getting started in 
their careers?
I guess the key thing is to do what you are 
interested in, and keep your focus on the 
curiosity that will drive your efforts in 
science. If you start working on some-
thing you’re not really interested in, then 
you will most likely fail because you just 
can’t stay motivated. On the other hand, 
it’s also important not to give up. If you 
don’t get excited about fi  xing failed ex-
periments, then it’s going to be diffi  cult 
to stay in science because 90% of experi-
ments fail. One would do well to remem-
ber that on the days when nothing works. 
Frequently, the problem is not you—it’s 
the experiment.
I think science is a great job, and I 
really wonder why more young people 
are not excited about it. Maybe we don’t 
suffi  ciently promote the fact that it’s the 
greatest job on Earth.
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Taipale’s post-docs busily sort through the data from myriad RNAi screens.